We are live on ! Find out more

184 hedge funds and large institutions have $1.99B invested in Chemed in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 59 increasing their positions, 81 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $9.1M | Put options by funds: $4.69M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

1% less capital invested

Capital invested by funds: $2B → $1.99B (-$10.1M)

4.74% less ownership

Funds ownership: 125.55%120.81% (-4.7%)

5% less funds holding

Funds holding: 194184 (-10)

27% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 81

38% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 26

Holders
184
Holders Change
-10
Holders Change %
-5.15%
% of All Funds
5.27%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
16
Increased
59
Reduced
81
Closed
26
Calls
$9.1M
Puts
$4.69M
Net Calls
+$4.41M
Net Calls Change
-$2.95M

CHE Hedge Fund Activity: Q2 2014 in Review

184 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2014, worth a combined $1.99B — down 0.5% from $2B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CHE and 16 opened new positions — a net loss of 10 holders — while 81 trimmed existing stakes and 59 added.

The largest buyer was LSV Asset Management, adding an estimated $48.9M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $42.1M sold.

  • 184 institutional investors held Chemed (CHE) as of Q2 2014, down from 194 in Q1 2014.
  • Funds reported $1.99B of Chemed stock for Q2 2014, down 0.5% quarter-over-quarter.
  • 16 funds opened new Chemed positions in Q2 2014 and 26 closed out, a net change of -10 holders.
  • The largest Chemed buyer in Q2 2014 was LSV Asset Management, an estimated $48.9M added.
  • The largest Chemed seller in Q2 2014 was JP Morgan Chase, an estimated $42.1M sold.

Based on aggregated 13F filings for Q2 2014.